HNS Series™

Clinical Health Intelligence Product System

HNS Series™ is ProXplor™’s clinical health intelligence product system designed for medical and healthcare application scenarios.

Built upon ProXplor™’s research-driven health intelligence technologies, HNS Series™ integrates artificial intelligence, health intelligence models, functional assessment technologies, and clinical application capabilities to support healthcare institutions in intelligent health assessment, clinical research, and professional health management applications.

HNS Series™ represents ProXplor™’s clinical-grade product direction, developed for healthcare environments requiring higher standards of validation, reliability, and regulatory compliance.

Clinical Application Focus

Intelligent Health Technologies for Healthcare Institutions

HNS Series™ is designed to support healthcare organizations through intelligent health assessment technologies and professional application systems.

The product system focuses on:

  • Clinical health assessment applications;

  • Healthcare institution deployment;

  • Professional health evaluation workflows;

  • Clinical research and validation collaboration;

  • Intelligent healthcare technology integration.

HNS Series™ supports the evolution of healthcare services toward more intelligent, data-driven, and proactive health management models.

Clinical Research & Validation

HNS Series™ products are developed through dedicated clinical application companies and research partnerships in China, with different teams focusing on modern medicine and traditional Chinese medicine clinical application directions.

The related clinical application companies have established collaboration with leading academic and healthcare institutions, including:

  • Tsinghua University;

  • Zhejiang University;

  • Chinese Academy of Sciences;

  • Southeast University;

  • Nanjing University of Chinese Medicine.

Clinical application research and validation programs have been conducted with healthcare and research institutions, including:

  • Health Management Center of PLA General Hospital (301 Hospital);

  • Institute of Aviation Medicine, Air Force;

  • Jiangsu Provincial Hospital of Chinese Medicine;

  • Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine.

The health data calibration framework references astronaut health standards.

Clinical validation research was completed before 2019, with a validated sample size of:

344 cases

Medical Device & Industrialization Achievements

HNS Series™ products are developed through medical device manufacturing enterprises with established technology commercialization capabilities.

Key achievements include:

  • China Class II medical device registrations;

  • More than 70 registered intellectual property assets across related companies;

  • Recognition of Yuanjian Technology (Hangzhou) Co., Ltd. as a National High-Tech Enterprise in China in 2022;

  • Deployment experience in large healthcare institutions.

To date:

  • More than 1,000 clinical application devices have been deployed in major healthcare institutions in China;

  • More than 20,000 non-clinical health assessment devices have been deployed in wellness markets;

  • Related technologies have supported more than 100 million health service interactions in China.

Application Scenarios

HNS Series™ supports:

  • Hospitals;

  • Medical examination centers;

  • Clinical research institutions;

  • Integrated medicine organizations;

  • Professional healthcare providers.

Through intelligent health assessment technologies, HNS Series™ helps healthcare organizations improve assessment capabilities, enhance service efficiency, and explore innovative proactive healthcare models.

Current Market Availability

Mainland China Market Only

Currently, HNS Series™ products are available exclusively for clinical applications within the mainland China market.

Due to differences in medical device regulations, clinical standards, and healthcare systems across countries and regions, international commercialization of HNS Series™ will be evaluated separately based on local regulatory requirements and strategic partnerships.

Powered by ProXplor™ Health Intelligence Infrastructure

HNS Series™ is supported by ProXplor™’s core technology foundation, including:

ProXplor Research Framework™

A systems science–driven methodology for health-state modeling and intelligent health research.

ProXplor Nexus™

A health intelligence foundation model and AI reasoning platform supporting:

  • Multimodal health analysis;

  • Intelligent health inference;

  • Health-state interpretation;

  • Professional health applications.

Through the integration of scientific research, artificial intelligence, medical device capabilities, and clinical application expertise, HNS Series™ represents ProXplor™’s commitment to advancing intelligent healthcare innovation.

Advancing Clinical Health Intelligence

HNS Series™ represents ProXplor™’s approach to connecting advanced health intelligence technologies with clinical healthcare applications.

By combining scientific research, artificial intelligence, and validated healthcare applications, HNS Series™ supports the transition toward more intelligent, precise, and proactive healthcare systems.

Important Notice

HNS Series™ products are developed for clinical and healthcare application scenarios and are subject to applicable medical device regulations and market authorization requirements.

Availability, regulatory status, and application scope may vary by country and region. Please refer to local regulatory requirements and authorized channels.